GelStat Corporation (GSAC)

Market Cap	935.11K +4.2%
Revenue (ttm)	363.53K +71.2%
Net Income	-283.40K
EPS	-0.00
Shares Out	3.74B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	308,449
Average Volume	2,270,594
Open	0.0002
Previous Close	0.0003
Day's Range	0.0002 - 0.00025
52-Week Range	0.0002 - 0.0005
Beta	1.26
RSI	46.29
Earnings Date	n/a

About GelStat

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms. The company sells its products to retailers, wholesalers, specialt...

• Industry: Software - Infrastructure
• Sector: Technology
• Founded: 2002
• Employees: 2
• Stock Exchange: OTCMKTS
• Ticker Symbol: GSAC

Financial Performance

In 2024, GelStat's revenue was $349,730, an increase of 133.89% compared to the previous year's $149,527. Losses were -$372,947, 77.5% more than in 2023.